UnitedHealth Group Incorporated (NYSE:UNH) Position Increased by Private Trust Co. NA

Private Trust Co. NA lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,767 shares of the healthcare conglomerate’s stock after acquiring an additional 436 shares during the quarter. Private Trust Co. NA’s holdings in UnitedHealth Group were worth $4,068,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of UNH. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new position in UnitedHealth Group in the 4th quarter worth approximately $26,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $28,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $30,000. Finally, Promus Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth about $32,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the company’s stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer owned 10,398 shares of the company’s stock, valued at $3,171,390. This represents a 5.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Kristen Gil bought 3,700 shares of the business’s stock in a transaction that occurred on Thursday, May 15th. The stock was purchased at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the purchase, the director directly owned 3,818 shares of the company’s stock, valued at $1,035,327.06. This represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 109,408 shares of company stock valued at $31,607,768 in the last three months. Company insiders own 0.28% of the company’s stock.

UnitedHealth Group Stock Down 5.7%

UnitedHealth Group stock opened at $307.69 on Thursday. The firm has a market cap of $279.12 billion, a price-to-earnings ratio of 12.88, a P/E/G ratio of 1.55 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The firm has a fifty day moving average price of $329.50 and a two-hundred day moving average price of $450.21.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the firm earned $6.91 earnings per share. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.87%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio is currently 37.02%.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on UNH shares. HSBC restated a “reduce” rating and set a $270.00 price objective (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Morgan Stanley decreased their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a research note on Wednesday, May 14th. Wolfe Research reduced their price objective on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a research report on Tuesday, May 20th. UBS Group reduced their price objective on UnitedHealth Group from $400.00 to $385.00 and set a “buy” rating for the company in a research report on Wednesday, June 25th. Finally, TD Cowen lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target for the company. in a report on Monday, May 19th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $415.57.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.